Journal
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 8, Issue 4, Pages 417-425Publisher
EXPERT REVIEWS
DOI: 10.1586/17474124.2014.893822
Keywords
immunomodulators; breastfeeding; biologic; antibiotics; inflammatory bowel disease; Crohn's disease; pregnancy; fertility; aminosalicylates; ulcerative colitis
Categories
Funding
- UCB
Ask authors/readers for more resources
Management of inflammatory bowel disease in women of reproductive age requires special attention. Even though fertility in women without previous pelvis surgery is similar to the general population, active disease at conception and during pregnancy can lead to unfavorable pregnancy and fetal outcomes. In general, most medications needed to treat inflammatory bowel disease are low risk during pregnancy and breastfeeding. Achieving and maintaining disease remission, patient education, and a multidisciplinary team approach is the key to a successful pregnancy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available